<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — December 2023]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400881/pharma-december-2023</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 04:40:23 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400881.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 01 Dec 2023 05:40:46 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — December 2023 on Wed, 27 Dec 2023 07:24:04 GMT]]></title><description><![CDATA[<p dir="auto">Astrazeneca klar til at foretage et af de første opkøb i Kina <a href="https://www.proinvestor.com/investornyt/1096052/astrazeneca-klar-til-at-foretage-et-af-de-forste-opkob-i-kina" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1096052/astrazeneca-klar-til-at-foretage-et-af-de-forste-opkob-i-kina</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037971</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037971</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 27 Dec 2023 07:24:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Tue, 26 Dec 2023 11:36:15 GMT]]></title><description><![CDATA[<p dir="auto">Bristol Myers Squibb To Acquire RayzeBio For $62.50/share In All-cash Deal <a href="https://www.proinvestor.com/investornyt/1095756/bristol-myers-squibb-to-acquire-rayzebio-for-6250-share-in-all-cash-deal" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1095756/bristol-myers-squibb-to-acquire-rayzebio-for-6250-share-in-all-cash-deal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037969</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037969</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Tue, 26 Dec 2023 11:36:15 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Tue, 26 Dec 2023 07:38:13 GMT]]></title><description><![CDATA[<p dir="auto">AstraZeneca To Buy Gracell For Up To $1.2 Bln <a href="https://www.proinvestor.com/investornyt/1095718/astrazeneca-to-buy-gracell-for-up-to-12-bln" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1095718/astrazeneca-to-buy-gracell-for-up-to-12-bln</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037966</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037966</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 26 Dec 2023 07:38:13 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Sat, 23 Dec 2023 04:47:46 GMT]]></title><description><![CDATA[<p dir="auto">ALK får lavere kursmål hos Kempen<br />
22.12.2023 17.12 • MarketWire •<br />
ALK-Abelló har fået reduceret kursmålet for aktien til 150 kr. fra 200 kr. hos Kempen.</p>
<p dir="auto">Anbefalingen er uændret "køb".</p>
<p dir="auto">Det fremgår af Bloomberg.</p>
<p dir="auto">Aktien faldt fredag 0,3 pct. til 99 kr.</p>
<p dir="auto">.\˙ MarketWire</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037968</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037968</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 23 Dec 2023 04:47:46 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Sat, 16 Dec 2023 04:28:30 GMT]]></title><description><![CDATA[<p dir="auto">Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know <a href="https://www.proinvestor.com/investornyt/1091668/eli-lilly-lly-dips-more-than-broader-market-what-you-should-know" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1091668/eli-lilly-lly-dips-more-than-broader-market-what-you-should-know</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037965</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037965</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 16 Dec 2023 04:28:30 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Sat, 16 Dec 2023 04:27:08 GMT]]></title><description><![CDATA[<p dir="auto">AbbVie (ABBV) Declines More Than Market: Some Information for Investors <a href="https://www.proinvestor.com/investornyt/1091670/abbvie-abbv-declines-more-than-market-some-information-for-investors" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1091670/abbvie-abbv-declines-more-than-market-some-information-for-investors</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037970</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037970</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 16 Dec 2023 04:27:08 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Thu, 14 Dec 2023 04:18:02 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer har øretæver i sigte efter skuffende prognose for næste år <a href="https://www.proinvestor.com/investornyt/1089999/pfizer-har-oretaever-i-sigte-efter-skuffende-prognose-for-naeste-ar" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1089999/pfizer-har-oretaever-i-sigte-efter-skuffende-prognose-for-naeste-ar</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037961</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037961</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 14 Dec 2023 04:18:02 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Tue, 12 Dec 2023 14:45:55 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen <a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-all-required-regulatory-approvals-complete" rel="nofollow ugc">https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-all-required-regulatory-approvals-complete</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037964</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037964</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 12 Dec 2023 14:45:55 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Tue, 12 Dec 2023 04:38:39 GMT]]></title><description><![CDATA[<p dir="auto">Sanofi Terminates Pompe Disease Drug Agreement With Maze Therapeutics Following FTC Opposition <a href="https://www.proinvestor.com/investornyt/1089315/sanofi-terminates-pompe-disease-drug-agreement-with-maze-therapeutics-following-ftc-opposition" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1089315/sanofi-terminates-pompe-disease-drug-agreement-with-maze-therapeutics-following-ftc-opposition</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037962</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037962</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 12 Dec 2023 04:38:39 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Mon, 11 Dec 2023 17:04:58 GMT]]></title><description><![CDATA[<p dir="auto">Danske Bank ser opkøb som mulig bro over truende patentkløft for Lundbeck <a href="https://www.proinvestor.com/investornyt/1088791/danske-bank-ser-opkob-som-mulig-bro-over-truende-patentkloft-for-lundbeck" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1088791/danske-bank-ser-opkob-som-mulig-bro-over-truende-patentkloft-for-lundbeck</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037957</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037957</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 11 Dec 2023 17:04:58 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Mon, 11 Dec 2023 03:59:40 GMT]]></title><description><![CDATA[<p dir="auto">AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH <a href="https://www.proinvestor.com/investornyt/1088753/astrazeneca-phase-iii-trial-data-show-danicopan-sustained-clinical-improvements-in-pnh" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1088753/astrazeneca-phase-iii-trial-data-show-danicopan-sustained-clinical-improvements-in-pnh</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037967</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037967</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 11 Dec 2023 03:59:40 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Mon, 11 Dec 2023 03:59:09 GMT]]></title><description><![CDATA[<p dir="auto">Novartis : Phase III Trial Results Show Sustained Efficacy &amp; Long-term Safety Of Fabhalta In PNH <a href="https://www.proinvestor.com/investornyt/1088751/novartis-phase-iii-trial-results-show-sustained-efficacy-amp-long-term-safety-of-fabhalta-in-pnh" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1088751/novartis-phase-iii-trial-results-show-sustained-efficacy-amp-long-term-safety-of-fabhalta-in-pnh</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037963</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037963</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 11 Dec 2023 03:59:09 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Mon, 11 Dec 2023 03:57:07 GMT]]></title><description><![CDATA[<p dir="auto">Astellas' Veoza Approved In Europe For Treatment Of Vasomotor Symptoms Associated With Menopause <a href="https://www.proinvestor.com/investornyt/1088746/astellas-veoza-approved-in-europe-for-treatment-of-vasomotor-symptoms-associated-with-menopause" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1088746/astellas-veoza-approved-in-europe-for-treatment-of-vasomotor-symptoms-associated-with-menopause</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037960</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037960</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 11 Dec 2023 03:57:07 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:40:05 GMT]]></title><description><![CDATA[<p dir="auto">Kilde: Nordnet</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037959</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037959</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:40:05 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:40:00 GMT]]></title><description><![CDATA[<p dir="auto">Valuta<br />
EURUSD | +0,2% | 1,0906 dollar<br />
USDJPY | -0,1% | 148,08 yen<br />
EURJPY | +0,1% | 161,53 yen<br />
GBPUSD | +0,1% | 1,2640 dollar</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037955</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037955</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:40:00 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:39:50 GMT]]></title><description><![CDATA[<p dir="auto">Råvarer<br />
Brent spot | +0,2% | 80,58 dollar<br />
WTI spot | +0,4% | 75,86 dollar<br />
Guld spot | +0,2% | 2039,81 dollar</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037952</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037952</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:39:50 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:39:38 GMT]]></title><description><![CDATA[<p dir="auto">Derfor vil der også blive holdt skarpt øje med eftermiddagens tal fra den amerikanske centralbankchef, Jerome Powell. Flere af de regionale Federal Reserve-chefer har allerede indikeret, at den nuværende rente kan være tilstrækkelig. Spørgsmålet er så, om Jerome Powell vil gentage den retorik i sin tale, eller om han vil forsøge at dæmpe markedets forventninger.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037956</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037956</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:39:38 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:39:26 GMT]]></title><description><![CDATA[<p dir="auto">Efter en solid slutspurt endte de amerikanske aktier med pæne plusser trods stigende renter. Det ser dog mere trægt ud fredag i det amerikanske futuresmarked, hvor de ledende indeks falder en smule tilbage.<br />
Stemningen på de europæiske markeder er dog bedre, og det toneangivende tyske DAX-indeks indikeres op med 0,3 pct. inden åbningen.<br />
Efter opløftende inflationstal fra både eurozonen og USA er troen på, at inflationen kan komme ned omkring 2 pct. med det nuværende renteniveau, steget.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037954</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037954</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:39:26 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:38:53 GMT]]></title><description><![CDATA[<p dir="auto">01.12.2023<br />
Dagens vigtigste nyheder</p>
<p dir="auto">Ørsted får muligheden for at byde ind på en ny vindauktion i New York<br />
De amerikanske aktier endte torsdag med pæn fremgang<br />
Markedet ser frem mod den amerikanske centralbankchefs tale i eftermiddag</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037958</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037958</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:38:53 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — December 2023 on Fri, 01 Dec 2023 06:32:15 GMT]]></title><description><![CDATA[<p dir="auto">DNB ser opkøb hjælpe Lundbecks pipeline før patentudløb for Rexulti <a href="https://www.proinvestor.com/investornyt/1084773/dnb-ser-opkob-hjaelpe-lundbecks-pipeline-for-patentudlob-for-rexulti" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1084773/dnb-ser-opkob-hjaelpe-lundbecks-pipeline-for-patentudlob-for-rexulti</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037953</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037953</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 01 Dec 2023 06:32:15 GMT</pubDate></item></channel></rss>